Navigation Links
FDA Approves 'Plan B' Pill for 17-Year-Olds
Date:4/22/2009

Decision is latest involving controversial birth-control drug

WEDNESDAY, April 22 (HealthDay News) -- Responding to a federal judge's directive, the U.S. Food and Drug Administration said Wednesday that it will now allow 17-year-olds to get the controversial "morning-after" birth control pill without a doctor's prescription.

In 2006, the FDA said it would limit over-the-counter access to the pill, also known as Plan B, to women 18 and older. But U.S. District Judge Edward R. Korman ruled last month in a New York lawsuit that the FDA had to reconsider whether to make the drug available to all women, regardless of age, without a prescription. He ordered the agency to let 17-year-olds get the drug, and separately to evaluate whether all age restrictions should be lifted.

"On March 23, 2009, a federal court issued an order directing the FDA, within 30 days, to permit the Plan B drug sponsor to make Plan B available to women 17 and older without a prescription," the agency said in a statement issued Wednesday afternoon on its Web site. "The government will not appeal this decision. In accordance with the court's order, and consistent with the scientific findings since 2005 by the Center for Drug Evaluation and Research, FDA sent a letter to the manufacturer of Plan B that the company may, upon submission and approval of an appropriate application, market Plan B without a prescription to women 17 years of age and older."

Plan B is an extra high dose of regular birth control that needs to be taken within 72 hours of unprotected intercourse to be effective. Essentially, the drug prevents pregnancy by delaying ovulation. It does not interrupt an already implanted pregnancy.

Religious conservatives object to Plan B, saying it is the equivalent of an abortion pill because it can prevent a fertilized egg from attaching to the uterus, and could also encourage premarital sex.

Supporters of broader access to
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
2. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
3. FDA Approves New Indication for Wyeths TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
4. U.S. FDA Approves New THERAKOS(TM) CELLEX(TM) Photopheresis System
5. FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
6. FDA Approves Two Hologic HPV Tests
7. U.S. Food and Drug Administration Approves New Female Condom
8. Congress Approves FY2009 Omnibus Appropriations Bill with $900 Million for The Global Fund
9. FDA approves ULORIC (febuxostat) for the chronic management of hyperuricemia in patients with gout
10. State Health Department Approves Closure Plan for Brownsville Tri-County Hospital
11. NUCRYST Approves $0.80 Per Share Cash Distribution to Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves 'Plan B' Pill for 17-Year-Olds
FDA Approves 'Plan B' Pill for 17-Year-Olds
(Date:12/5/2009)WASHINGTON, Dec. 5 ,, What: Cuts for a Cause ,, Why: To make a difference in the fight against cancer and other terminal illnesses affecting children. All proceeds from each hair service given
(Date:12/5/2009)Research debunks the ,something,s wrong with being single, myth , , SATURDAY, Dec. 5 (HealthDay News) -- Pity the poor single people who pass their 40th birthday without ever tying the knot, s
(Date:12/4/2009)PALO ALTO, Calif., Dec. 4 Varian Medical Systems (NYSE: VAR ) announced today that its Board of Directors has set the regular 2010 Annual Meeting of Stockholders for February 11, 2010 with a record
(Date:12/4/2009)WASHINGTON, Dec. 4 The American Association of Homes and Services for the Aging (AAHSA) applauds the Senate for ensuring that the Community Living and Supportive Services (CLASS) provisions remain i
(Date:12/4/2009)WASHINGTON, Dec. 4 While Congress debates whether health care reform would control health care costs, Leapfrog,s purchaser members point to 45 hospitals that lead through example -- delivering the be
Breaking Medicine News(10 mins):Health News:Never Married, Over 40, Well-Adjusted 2Health News:Never Married, Over 40, Well-Adjusted 3Health News:Varian Medical Systems Schedules Annual Stockholder Meeting in Palo Alto 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3
..., April 24 Prime Therapeutics (Prime), a,thought ...oday that,Rachelle Wan, RPh, has joined the organi...ns., As Vice President of Pharmacy Trade Relation...rategic pharmacy,contracts and the performance of ...
...April 24 Life Brokerage Partners,announces three ...ms with,Peach Holdings, Inc. ("Peachtree"), Polari...premium finance programs are particularly valuable... and UNF,do not end with the agents, but extend to...
... Reveals Americans Are in Overdrive, Trend Exper...s Expert Denise Austin Offers Nightl...fter a long day at the,office, do you reach for yo...er than ever before, often at the expense of,their...
..., N.J., April 24 Cambrex,Corporation (NYSE: CBM ...8,financial results on Thursday, May 1, 2008 after...i-bin/prnh/20000613/CAMBREXLOGO ), The Company w... Thursday, May 1, 2008 at 5:00 p.m. Easter...
...homa Society and Ralph Lauren Center for Cancer Ca...Be Certified, NEW YORK, April 24 The Harold P. F...d that representatives from the Leukemia,& Lymphom...nic were the first to be trained in patient naviga...
...l 23 Young Innovations, Inc.,(Nasdaq: YDNT ) tod...1,2008., Sales for the first quarter of 2008 were...% from the $22.9 million reported in the first qua...come,was essentially unchanged at $2.8 million, co...
Other Medicine News:Health News:Life Brokerage Partners Strengthens Premium Finance Programs 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 2Health News:Wired, Working Americans Let Nighttime Health Routines Slide 3Health News:Wired, Working Americans Let Nighttime Health Routines Slide 4Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 2Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 3Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 4Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 5Health News:Harold P. Freeman Patient Navigation Institute Completes First Trainings and Certifications 6Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 2Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 3Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 4Health News:Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008 5
(Date:12/4/2009)EMERYVILLE, Calif., Dec. 4 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that it will host an investor teleconference and webcast. Principal investigators will discuss the data present
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today the presentation of new d
(Date:12/4/2009)ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is prese
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 2PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 3PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 4PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6William Dwyer Named to PerfectServe Advisory Board 57496 1William Dwyer Named to PerfectServe Advisory Board 57496 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 1Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 2Photos 3A The Makers of LISTERINE 28R 29 and REACH 28R 29 TOTAL CARE Products Unveil a New Laugh Out Loud Book Benefiting the National Childrens Oral 57494 3Cyberonics to Present at Maxim Group Growth Conference 57492 1Cyberonics to Present at Maxim Group Growth Conference 57492 2
... Reported Safety & Tolerability Profile,in Sub...CHICAGO, June 25 /PRNewswire-FirstCall/ -- Phase I...of the American Diabetes,Association demonstrated ...dase-4 (DPP-4) in development by Bristol-Myers,Squ...), in,combination with metformin, exhibited a stat...
...-Funded Immune Globulin Study Uncovers Sample,Mani...PRNewswire-USNewswire/ -- An analysis,released tod...,study ruling out a link between autism and Rh imm...ained the mercury-based,preservative thimerosal. B...red manipulation of the study sample, so that,earl...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 2Genetics Journal Thimerosal/Autism Study the 'Best Science Drug,Company Money Can Buy' 3
QuikCoag CaCl2
QuikCoag Control 2
..., compact design. Using optical light scatter for ...YN 3200 meets the needs of today's laboratory. The...-part differential analysis, automated sample hand...y. The system combines proven Multi-Angle Polarize...
Perclose A-T Suture-Mediated Closure
Medicine Products: